Branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination

In this article, we report two patients who experienced the first onset of branch retinal vein occlusion (BRVO) 3 days after the administration of the BNT162b2 (Pfizer–BioNTech) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Case 1: A 50-year-old woman without any history of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hayato, Nagasato, Daisuke, Nakakura, Shunsuke, Nagasawa, Toshihiko, Wakuda, Hiroyuki, Kurusu, Akihiro, Mitamura, Yoshinori, Tabuchi, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262010/
https://www.ncbi.nlm.nih.gov/pubmed/35813793
http://dx.doi.org/10.4103/tjo.tjo_24_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262010/
https://www.ncbi.nlm.nih.gov/pubmed/35813793
http://dx.doi.org/10.4103/tjo.tjo_24_22

Ejemplares similares